- Home
- TSSI vs IMTX Comparison
TSSI vs IMTX Comparison
Compare TSSI & IMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TSSI
- IMTX
- Stock Information
- Founded
- TSSI 2004
- IMTX N/A
- Country
- TSSI United States
- IMTX Germany
- Employees
- TSSI N/A
- IMTX N/A
- Industry
- TSSI Professional Services
- IMTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TSSI Consumer Discretionary
- IMTX Health Care
- Exchange
- TSSI Nasdaq
- IMTX Nasdaq
- Market Cap
- TSSI 677.8M
- IMTX 653.9M
- IPO Year
- TSSI N/A
- IMTX N/A
- Fundamental
- Price
- TSSI $15.40
- IMTX $5.69
- Analyst Decision
- TSSI
- IMTX Strong Buy
- Analyst Count
- TSSI 0
- IMTX 4
- Target Price
- TSSI N/A
- IMTX $14.67
- AVG Volume (30 Days)
- TSSI 3.5M
- IMTX 572.9K
- Earning Date
- TSSI 08-06-2025
- IMTX 08-13-2025
- Dividend Yield
- TSSI N/A
- IMTX N/A
- EPS Growth
- TSSI 311.74
- IMTX N/A
- EPS
- TSSI 0.34
- IMTX N/A
- Revenue
- TSSI $263,021,000.00
- IMTX $152,823,253.00
- Revenue This Year
- TSSI N/A
- IMTX N/A
- Revenue Next Year
- TSSI N/A
- IMTX $1.92
- P/E Ratio
- TSSI $43.93
- IMTX N/A
- Revenue Growth
- TSSI 328.79
- IMTX 83.61
- 52 Week Low
- TSSI $4.13
- IMTX $3.30
- 52 Week High
- TSSI $31.94
- IMTX $13.09
- Technical
- Relative Strength Index (RSI)
- TSSI 33.85
- IMTX 41.21
- Support Level
- TSSI $13.88
- IMTX $5.42
- Resistance Level
- TSSI $15.63
- IMTX $6.47
- Average True Range (ATR)
- TSSI 1.96
- IMTX 0.36
- MACD
- TSSI -0.80
- IMTX -0.11
- Stochastic Oscillator
- TSSI 8.52
- IMTX 21.77
About TSSI TSS Inc. Common Stock
TSS Inc provides various services for planning, design, development, and maintenance of mission-critical facilities and information infrastructure, as well as integration services. Its services consist of technology consulting, design and engineering, project management, systems integration, systems installation, facilities management, and IT procurement services. The activities are organized into two segments: Procurement, Systems Integration, and Facilities Management. It generates the majority of its revenue from the Procurement segment.
About IMTX Immatics N.V.
Immatics NV is a biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.